IL1B and neoplasm: Our results showing the importance of IL-1β as a regulator of pathogenic PD-L1 expression in tumor cells may provide a scientific basis for further understanding of PD-L1–PD-1 axis signaling and for development of novel agents to inhibit PD-L1 expression and thereby to promote the immune-mediated elimination of tumors.